Related Experiment Video
Updated: Aug 16, 2026
Simple Continuous Glucose Monitoring in Freely Moving Mice
Published on: February 24, 2023
The continuous glucose monitoring sensor in neonatal intensive care
K Beardsall1, A L Ogilvy-Stuart, J Ahluwalia
1University of Cambridge, Department of Paediatrics, Addenbrooke's Hospital, Hills Road, Cambridge CB2 2QQ, UK. kb274@cam.ac.uk
Insights
Continuous glucose monitoring is feasible in very low birthweight infants, offering detailed insights into glucose control. This technology is practical for neonatal intensive care units, aiding in managing glucose abnormalities.
Area of Science:
- Neonatal intensive care
- Pediatric endocrinology
- Medical device technology
Background:
- Very low birthweight infants face significant risks of glucose control abnormalities.
- Effective glucose monitoring is crucial for managing these high-risk neonates.
Purpose of the Study:
- To assess the feasibility of continuous glucose monitoring (CGM) in very low birthweight infants.
- To evaluate the practicality and tolerability of CGM in the neonatal intensive care setting.
Main Methods:
- A study involving sixteen very low birthweight infants was conducted within 24 hours of delivery.
- Continuous glucose monitoring sensors were applied and data collected for up to seven days.
Main Results:
- Subcutaneous glucose sensors demonstrated good tolerability in the studied infants.
- The readings obtained from CGM were comparable to those from near-patient whole blood monitoring devices.
Conclusions:
- Continuous glucose monitoring is a practical and viable method for neonates.
- CGM provides detailed and valuable information regarding glucose control in infants, supporting clinical management.
Objective:
To determine the feasibility of continuous glucose monitoring in the very low birthweight baby requiring intensive care, as these infants are known to be at high risk of abnormalities of glucose control.
Method:
Sixteen babies were studied from within 24 hours of delivery and for up to seven days.
Results:
The subcutaneous glucose sensors were well tolerated and readings were comparable to those on near patient whole blood monitoring devices.
Conclusion:
Continuous glucose monitoring is practical in neonates, giving detailed information about glucose control.
